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The prevalence of obesity, or excessive TG accumulation in adipose tissue, results from dietary excess and is
increasing in many parts of the world. Obesity is a risk factor for several diseases, including cardiovascular disease,
T2D, and cancer. A growing consensus exists, however,
that obesity is protective against the adverse biochemical
effects of caloric excess (1–4). Several studies have shown
that obesity and T2D are accompanied by increases in
FFAs, ceramides, DAG, and other potentially toxic lipids
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in various tissues (5–9). These lipid mediators induce cellular stress known as lipid toxicity or “lipotoxicity” (4, 10,
11). Therefore, it is of interest to learn the mechanisms
that enable animals to store excess carbons safely as TG in
the face of caloric overload.
In Drosophila, a high sugar (HS) diet induces obesity accompanied by hyperglycemia, hyperlipidemia, and insulin
resistance (12–16). Interestingly, the ability to convert dietary sugar into stored fat was protective against the effects
of caloric overload, as lean mutants were unable to survive
on HS diets (14, 17). We showed that carbon flux into esterified fat was blunted after chronic HS feeding, consistent
with a limited ability of animals to convert dietary sugar into
TG (17). The Drosophila fat body (FB) stores and metabolizes fat during feeding and starvation, and also controls
whole-animal glucose disposal. Both larvae and adult flies
become hyperglycemic and insulin resistant when their capacity to store fat is exceeded (17, 18). This is consistent
with the model of “adipose tissue expandability” proposed
as a mechanism of insulin resistance (19, 20). This model
holds that the ability to increase the storage of fatty acids as
inert TG is protective against metabolic disease. Consistent
with this model, increasing adipose volume or fat content is
protective, whereas exceeding the maximum capacity of
adipose fat storage is deleterious. Based on our expression
and metabolomic analyses in HS-fed larvae, we propose that
CoA levels tightly regulate the FB’s maximum storage capacity by limiting TG synthesis.
CoA is required in all organisms, functioning as a cofactor for an estimated 4% of enzymes and in more than 100
different reactions (21, 22). CoA is required for fatty acid
synthesis by acting as a cosubstrate for fatty acid synthase
(23, 24) and CoA is also required in order to esterify fatty
acid substituents (25). Beta-oxidation requires two CoAs,
Abbreviations: FB, fat body; HS, high sugar; PA, pantothenic acid; PK,
pantothenate kinase; PPCS, phosphopantothenoylcysteine synthase.
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Abstract We developed a Drosophila model of T2D in
which high sugar (HS) feeding leads to insulin resistance. In
this model, adipose TG storage is protective against fatty
acid toxicity and diabetes. Initial biochemical and gene expression studies suggested that deficiency in CoA might underlie reduced TG synthesis in animals during chronic HS
feeding. Focusing on the Drosophila fat body (FB), which is
specialized for TG storage and lipolysis, we undertook a series of experiments to test the hypothesis that CoA could
protect against the deleterious effects of caloric overload.
Quantitative metabolomics revealed a reduction in substrate availability for CoA synthesis in the face of an HS
diet. Further reducing CoA synthetic capacity by expressing
FB-specific RNAi targeting pantothenate kinase (PK orfumble)
or phosphopantothenoylcysteine synthase (PPCS) exacerbated
HS-diet-induced accumulation of FFAs. Dietary supplementation with pantothenic acid (vitamin B5, a precursor of
CoA) was able to ameliorate HS-diet-induced FFA accumulation and hyperglycemia while increasing TG synthesis.
Taken together, our data support a model where free CoA is
required to support fatty acid esterification and to protect
against the toxicity of HS diets.—Musselman, L. P., J. L.
Fink, and T. J. Baranski. CoA protects against the deleterious effects of caloric overload in Drosophila. J. Lipid Res.
2016. 57: 380–387.

Hemolymph was collected and shipped frozen. All metabolite extraction was done by Metabolon. GC-MS (glycerol, cysteine) and
LC-MS (positive ion monitoring mode; pantothenate, carnitine,
palmitoyl-carnitine, and oleoyl-carnitine) were used to isolate the
peaks representing each analyte, with injection standards used at
fixed concentrations to quantify the relative amounts of each metabolite in six biological replicates per diet. Metabolites were
identified by automated comparison of the ion features in the
extracted samples to a reference library as described previously
(29). Metabolite levels were normalized to protein content for
FB, and to total volume for hemolymph.

CoA-SH determination
Eighty wild-type (w1118) wandering third-instar larvae were homogenized in 10 mM DTT/water and frozen at ⫺80°C. Homogenates were defrosted, TCA precipitated, and washed six times
with ether to remove lipids. Aqueous fractions were dried, resuspended, and run on a Waters HPLC, as described (17).

Metabolic assays
TG, FFA, and glycogen were assayed from groups of six frozen
wandering L3 larvae as previously described (17). Hemolymph
was isolated from groups of five to twenty wandering larvae and
assayed as previously described (17).

MATERIALS AND METHODS
Genetics
Wild-type w1118 lines were from the Vienna Drosophila Resource
Center. TRiP control, UAS-PKi and UAS-PPCSi (stocks GL00149
and JF03206, respectively) UAS-RNAi lines were from Harvard’s
DRSC TRiP collection. UAS-Dcr2; r4-GAL4 was used to express
transgenes in the larval FB (28).

Diets
The control (0.15 M sucrose) and HS (0.7 M sucrose) diets
were made using a modified Bloomington semi-defined food as
described previously (12). D-PA hemicalcium salt was from Sigma
(P5155) and was added in a volume of 30 l to a final concentration of 0.3 to 3 mM, with 3 mM producing optimal phenotypic
rescue. Water (30 l) was added to HS food as a control in these
experiments. Wild-type w1118 were used in PA supplementation
experiments.

Expression analyses
1118

FBs were isolated from wild-type w ; UAS-Dcr2; r4-GAL4 or
w ; UAS-Dcr2; cg-GAL4 wandering third-instar larvae and RNA
isolated and quantified as described using Illumina Hi-Seq (17).
Data from both control lines were pooled to increase power to
detect expression differences due to diet. A total of 13 biological
FB replicates per diet were analyzed over several lanes. These
data were deposited at GEO (GSE76214). For guts, six biological
replicates were isolated and RNA extracted. RT was used to make
cDNA, which was then analyzed by quantitative (q)PCR. Primers
used to detect vanin-like mRNA were 5′-TCCCGAGGATCAGATAAACC-3′ and 5′-ACAGGGTCACCAGAAACTCC-3′. Vanin-like levels
were normalized to RpL32 mRNA (CG7939) using 5′-CAGCATACAGGCCCAAGAT-3′ and 5′- GCACTCTGTTGTCGATACCC-3′.
Similar results were observed using a primer pair targeting a different region of vanin-like.
1118

PA, carnitine, acyl-carnitine, cysteine, and glycerol
determination
1118

FBs were isolated from wild-type w ; UAS-Dcr2; r4-GAL4
wandering third-instar larvae and immediately placed in PBS on
ice, then homogenized before shipping on dry ice to Metabolon.

RESULTS
In previous gene expression profiling experiments of
HS-fed insulin-resistant larvae, we saw a dramatic (10-fold)
increase in whole body expression of vanin-like (CG32754),
which is predicted to encode a CoA metabolic enzyme,
pantetheinase, that converts pantetheine to pantothenate
(also known as vitamin B5) and cysteamine (12). We previously observed changes in fatty acid synthesis and esterification, which require CoA, in HS-fed larvae (17). We
hypothesized that the increase in pantetheinase might be
evidence of a homeostatic response to defects in CoA availability. FlyAtlas (30) data shows the highest levels of vaninlike expression in the midgut, with expression only in midgut,
hindgut, and Malpighian tubule (flyatlas.org). Therefore,
we quantified vanin-like expression in isolated guts.
HS feeding increased expression of vanin-like in the
midgut by 4-fold (Fig. 1B), suggesting that the gut might
contribute to maintenance of systemic CoA levels by producing pantothenate to be used in other tissues when
CoA levels are depleted. We also observed a 50% increase
in expression of the putative pantothenate transporter,
CG10444, in gut RNA-seq, although edgeR did not identify
a significant difference (data not shown), consistent with a
need for pantothenate or CoA during HS feeding. Once
exported from the gut, circulating pantothenate could be
converted back into CoA to support fatty acid synthesis
and esterification in the FB, which is essential for larval
survival on a HS diet (17) (Fig. 1A).
We focused subsequent studies of expression and metabolism in the FB by using RNA-seq and metabolomics to
characterize CoA metabolism there. Thioester hydrolase
(encoded by CG1774), an enzyme that catalyzes the production of CoA-SH from acyl-CoA rather than pantothenate, was increased 3-fold at the mRNA level in whole
CoA protects against diet-induced diabetes
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one for each fatty acid to enter the mitochondrion and a
second CoA for thiolysis after transport (26). CoA also regulates intracellular redox state via its free sulfhydryl group
(25) and it regulates ketone biogenesis via acetyl-CoA (27).
In this study, we set out to identify metabolites that could
contribute to lipotoxicity in the face of caloric overload.
Our studies revealed that CoA levels were reduced, while
FFA levels were increased, in HS-fed larvae. Reducing FB
levels of pantothenate kinase (fumble, CG5725) or phosphopantothenyl cysteine synthase (PPCS, CG5629), both of
which catalyze steps in CoA synthesis from pantothenic acid
(PA), led to reduced TG storage and an increase in the severity of HS diet-induced fatty acid accumulation. By contrast, supplementing the HS diet with the CoA precursor,
PA, increased TG synthesis and lowered glucose and FFA
levels in the presence of caloric overload. Thus, CoA is limiting in the face of a HS diet, and we propose that increasing
CoA levels represents a novel therapeutic target for individuals with obesity-associated metabolic disorders.

animals (12). We observed a corresponding increase in
thioester hydrolase expression in FBs upon HS feeding (Fig.
1C). The transcriptional upregulation of both vanin-like
and thioester hydrolase in gut and FB, respectively, could occur in response to a deficit in CoA. CoA is required to produce fatty acid substrates for lipogenesis in the FB and for
over 100 other reactions (21, 22). Examining the pathway
more closely in FB gene expression datasets, we noted
upregulation of catalytic steps in CoA synthesis including
pantothenate kinase (CG5725, known as fumble in Drosophila;
Fig. 1D), although there was no change in expression of
genes encoding the enzymes PPCS and Ppcdc (Fig. 1E, F),
382
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which encode the intermediate steps in the CoA biosynthesis pathway. We also observed increases in mRNA
encoding two other enzymes that produce free CoA (PpatDpck and HMG-CoA synthase, Fig. 1G, H). Therefore, we
decided to study this pathway biochemically.
The gene expression results shown in Fig. 1 suggested
compensatory regulation of CoA production in HS-reared
larvae. Therefore, we hypothesized that CoA might limit
fatty acid esterification into TG in the face of a HS diet
(Fig. 2A). First, we characterized the levels of free CoA in
whole larvae reared on control or HS diets. HS feeding led
to a significant decrease in CoA concentrations in whole

Downloaded from www.jlr.org at Washington Univ Medical Library, on January 17, 2017

Fig. 1. HS diets increase expression of CoA metabolic enzymes. A: CoA metabolic pathway: pantothenate can be derived from the diet
and trafficked from the gut to the FB for CoA synthesis. CoA can also be derived from several intracellular sources. B–H: Gene expression
was quantified using tissue-specific qPCR [(B) guts] or RNA-seq [(C–H) FBs] from wild-type larvae reared on control (ctl) or 0.7M sucrose
(HS) diets. Pantetheinase, also known as vanin-like (B), thioesterhydrolase (C), fumble/pantothenate kinase (D), phosphopantothenoylcysteine synthase
(PPCS) (E), phosphopantothenoylcysteine decarboxylase (Ppcdc) (F), bifunctional phosphopantetheine adenylyltransferase-dephospho-CoA kinase (PpatDpck) (G), and HMG-CoA synthase (H).

third-instar larvae (Fig. 2B), consistent with a trend toward
decreased CoA shown in our previous work (17). Metabolomic analyses of FBs and hemolymph supported a role for
pantothenate in lipogenesis during challenge with HS diets. Pantothenate levels were decreased in the FB, consistent with an increase in shunting of pantothenate toward
CoA synthesis via increased pantothenate kinase expression in FBs from larvae fed HS diets (Fig. 2C). At the same
time, intermediates that require free CoA to promote lipid

metabolism accumulated in both the FB (glycerol and carnitine; Fig. 2D, E, respectively) and hemolymph (palmitoyl-carnitine and oleoyl-carnitine; Fig. 2F, G, respectively).
Glycerol requires CoA in order to generate TGs from
FFAs, whereas carnitine, palmitoyl-carnitine, and oleoylcarnitine all require CoA in order to promote fatty acid
␤-oxidation (Fig. 2A). Our metabolomic analyses were not
sensitive enough to detect free CoA or fatty acyl-CoAs in
these samples, but support the model nonetheless.

Downloaded from www.jlr.org at Washington Univ Medical Library, on January 17, 2017

Fig. 2. CoA may be limiting in HS-reared wild-type larvae. A: CoA and pantothenate (the ionic form of PA, which is required for the
synthesis of CoA) were observed in reduced quantities, whereas metabolites involved in the utilization of CoA were observed in increased
quantities, in HS-fed larvae. B: Free CoA-SH in whole larvae measured by HPLC; pantothenate (C), glycerol (D), carnitine (E), palmitoylcarnitine (F), oleoyl-carnitine (G). Parts (C–E) were extracted from isolated FBs and (F, G) were extracted from isolated hemolymph.

CoA protects against diet-induced diabetes
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we concluded that CoA is likely limiting for several processes on HS diets, including TG storage and fatty acid ␤oxidation. Therefore, we tested to determine whether we
could rescue some of the effects of HS diets by increasing
CoA levels. To do this, we supplemented the HS diet with
the CoA precursor, PA, to test whether it could increase the
ability of larvae to store TG when fed HS diets. PA supplementation significantly increased TG storage in HS-fed larvae (Fig. 4A) and reduced FFA concentrations (Fig. 4B). PA
supplementation also increased weight and reduced hemolymph glucose in larvae reared on HS diets, consistent with
a potential increase in insulin signaling (Fig. 4C, D). The
decrease in hemolymph glucose was likely not due to incorporation into disaccharides or polysaccharides because PA
did not affect levels of trehalose or glycogen (Fig. 4E, F). PA
supplementation did not affect free CoA-SH levels (Fig.
4G). We also tested whether PA could improve insulin sensitivity in cultured FBs, as measured by exogenous insulin
stimulation of Akt phosphorylation at serine 505. No significant improvement in insulin responsiveness was seen when
PO4-Akt was measured in insulin-stimulated FBs from wandering larvae reared on HS compared with HS + PA (4H).
As an additional dietary approach, we tested whether adding cysteine to pantothenate could improve any HS-induced

Fig. 3. FB-specific targeting of genes encoding enzymes in CoA synthesis exacerbates metabolic phenotypes resulting from challenge
with the HSD. UAS-Dcr2; r4-GAL4 transgenes were used to target fumble (PK, CG5725) or PPCS (CG5629) in the FB using transgenic RNAi.
TG (A), FFA (B), weights (C), and hemolymph glucose (D).
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Because steady-state levels of metabolites do not reflect the
metabolic flux through that pathway, we took a functional
approach to test whether the conversion of pantothenate to
CoA was important for tolerance of HS diets. We targeted two
enzymes that catalyze CoA synthesis from pantothenate, the
rate-limiting pantothenate kinase (PK also known as fumble,
CG5725) and phosphopantothenoylcysteine synthase (PPCS,
CG5629), which, like fumble, is required for growth of Drosophila S2 cells (31). Because the FB is the primary site of TG
synthesis in the fly, we used FB-specific RNAi to reduce CoA
biosynthesis from pantothenate by targeting PK/fumble and
PPCS in this tissue (Fig. 1A). The r4-GAL4 driver was used in
combination with a UAS-Dicer2 transgene to maximize degradation of endogenous mRNA. Knockdown of either gene
product led to reduced numbers of larvae on HS diets (not
shown), consistent with an essential role for CoA in supporting TG synthesis. Mutant larvae were leaner, with increased
FFA levels, when compared with wild-type controls reared on
the same HS diet (Fig. 3A, B). These larvae also exhibited
reduced size, compared with HS-fed wild-type larvae (Fig.
3C). Surprisingly, no increase in hemolymph glucose concentration was observed in either mutant (Fig. 3D).
Given that knockdown of the CoA synthetic enzymes,
pantothenate kinase and PPCS, exacerbated phenotypes,

Downloaded from www.jlr.org at Washington Univ Medical Library, on January 17, 2017

Fig. 4. PA supplementation of wild-type larvae increases metabolic flux into TG in the face of caloric overload. Whole animal TG (A),
whole animal FFA (B), weights (C), hemolymph glucose (D), hemolymph trehalose (E), whole animal glycogen (F), free CoA-SH (G), and
FB insulin sensitivity (H).

phenotypes, as cysteine also contributes to CoA synthesis
as a substrate for PPCS (Fig. 1A). No improvements were
observed relative to pantothenate supplementation, and
decreased weights were observed with cysteine alone, in
agreement with another recent study showing that flies do

not tolerate cysteine supplementation (32) (data not
shown). A modest but nonsignificant increase in FB cysteine levels was observed by LC-MS (1.5-fold, P < 0.2), suggesting that cysteine depletion was not a contributing factor to
the observed reduction in CoA.
CoA protects against diet-induced diabetes
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Previous studies have shown a reduced capacity for TG synthesis in obesity that is accompanied by increases in FFAs,
ceramides, and DAG, all potential mediators of lipotoxicity.
Still, it remains unknown what mechanisms limit the ability of
animals to store excess carbons from dietary sugar as TG. We
noticed a dramatic upregulation in the expression of CoA
synthetic enzymes that prompted us to take a closer look at
these steps of the pathway. The CoA pool is known to be limiting for several metabolic processes, including the TCA cycle, ketogenesis, lipogenesis, and mitochondrial fatty acid
import and ␤-oxidation (21, 26, 33). Although we did not
probe all of these pathways, our data support a model where
CoA is limiting in the face of caloric excess, reducing animal
fitness by contributing to metabolic lipotoxicity.
The Drosophila gut may be an important source of pantothenate. The fly gut is known to harbor commensal bacteria
that regulate nutritional status and might help to provide
pantothenate, as has been demonstrated in mammals (34–
36). We observed measurable quantities of this nutrient in
isolated guts, although no change in pantetheine or pantothenate levels was observed upon HS feeding (data not
shown). Increased gut expression of genes predicted to encode the pantetheine hydrolase vanin-like and the pantothenate transporter, CG10444, may represent an attempt of the
gut to compensate for inadequate CoA levels and suggests a
concerted systemic effort to provide this nutrient to the FB.
One open question is: what metabolites indicate an increased requirement for pantothenate in peripheral tissues? The carnitine-acyl carnitine system is one way in
which free CoA pools are maintained in cells (37, 38). Serum acyl-carnitine concentrations reflect an excess of intracellular acyl groups, increasing when fatty acid oxidation
is defective in the presence of increased FFAs (39, 40). It
follows that these acyl-carnitines might accumulate when
metabolic flux is reduced during insulin resistance. Increased long-chain carnitine esters have been observed
in the serum, liver, muscle, and urine of individuals with
obesity and T2D (41–46), although reduced levels of
long-chain acyl-carnitines have also been associated with
metabolic syndrome and T2D (47). Rodent models of obesity and T2D also accumulate acyl-carnitines (48–50). In
Drosophila, acyl-carnitines decline with age, along with obesity (51, 52). Perhaps circulating acyl-carnitines signal a
demand for CoA to enable proper fatty acid esterification
into TG in the FB and adipose. Our data support a model
where CoA bioavailability enables metabolic flexibility and
channeling of the endocrine fatty acid pool.
Another potential rate-limiting substrate for CoA synthesis in the face of caloric overload is cysteine (Fig. 1A),
although our data suggest that cysteine is not limiting in
the context of caloric overload. Cysteine supplementation
alone slightly reduced fitness on HS diets and did not rescue HS phenotypes (data not shown). Metabolite analysis
showed that cysteine levels were slightly elevated in HS-fed
FBs compared with controls. Further increasing cysteine
levels could adversely affect redox status in the FB, impairing cellular processes and masking any benefit to lipogenesis.

It is interesting to note that some studies have shown a
benefit for cysteine supplementation in T2D (53, 54). We
presume that a number of metabolites have the potential
to become rate-limiting under different physiological conditions. Nonetheless, our data support a substrate-limited
model where increasing the production of CoA benefits
animal health in the face of a HS diet.
PA is available over-the-counter as calcium pantothenate
in vitamin B5 supplements. In a recent study, pantothenate
supplementation promoted CoA-dependent ketogenesis
and improved liver function in an animal model of nonalcoholic fatty liver disease (23). We propose that vitamin B5
represents a potential therapy for insulin resistance resulting from overnutrition. Although pantothenate supplementation would be expected to increase adiposity, our work
suggests a significant benefit in terms of metabolic health.
PA’s low cost and toxicity profile make it an especially attractive target for future clinical studies.
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